Kineticann News
3 articles
growth-positive
במפגש בין תעשיית המזון והמשקאות לתעשיית הקנאביס
Kineticann, an Israeli company founded in 2018, is developing unique food ingredients based on the various components of the cannabis plant. The companys products are emulsions and soluble powders containing cannabis components. The companys CEO, Ofer Segal, believes that the cannabis plant has significant health benefits and can be used to create healthier food products. Kineticanns development is partly done in Israel and partly in Europe, with a subsidiary in Poland. The company is small, with five development employees and three professional advisors serving on its board of directors.
InvestmentExpand
growth-positive
Coming Soon to a Bar Near You: Cannabis-Infused Beer in Israel
Local companies Kaneh-B and Beer Bazaar are planning to make cannabis-infused beer available to the general Israeli public starting next month. The beer, called CannaBrew, will be legal in Israel as it only contains the plants legally-permitted aroma substances, not the prohibited cannabinoid component. Kaneh-B is also working on partnerships to expand their product offerings to include other food and beverage items infused with cannabis terpenes. The companies will initially launch two cannabis-infused beers with different effects. The event described in the article is set to happen in January 2020.
PartnersCustomers
growth-positive
Yom Chai Forms Strategic Partnership With Israeli Research and Development Company Kaneh-B to Conduct Scientific Clinical Trials on ADHD and to Distribute Approved European Dermal Products to Market
Yom Chai has entered into a strategic partnership with Kaneh-B to co-found the development and clinical validation of cannabis-based ADHD products. Yom Chai aims to bridge the gap between patients and doctors to bring scientifically validated products to the market. Kaneh-B, a research and development company, has developed a line of unique CBD and natural compound-based products. Six of Kaneh-Bs products have recently passed the necessary tests for European dermal product approval and will soon be available in various European countries through a network of distributors.
Partners
